2023 Form 5500 filing — Birmingham Hematology & Oncology Associates, LLC 401k Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011110931NAL0012406371005) for Birmingham Hematology & Oncology Associates, LLC 401k Plan, reported by Birmingham Hematology & Oncology Associates, LLC under EIN 52-2170293 and plan number 001. It reports 346 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011110931NAL0012406371005
Filing year
2023
Form type
2
Plan sponsor
Birmingham Hematology & Oncology Associates, LLC
EIN
52-2170293
Plan number
001
Location
Birmingham, AL
Participants
346
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$37,426,114
Net assets (EOY)
$37,426,114
Employer contributions
$1,383,884
Participant contributions
$1,050,278
Total income / additions
$7,682,080
Benefits paid
$7,340,892
Administrative expenses
$68,488
Total expenses
$7,409,380
Net increase / (decrease)
$272,700
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Capfinancial Partners LLCFINANCIAL ADVISOR$8,358not reported in the loaded dataset
Black & Pinckard LLCAUDITOR$1,550$0

Related Form 5500 pages